Market Intelligence Ecosystem
Hester Biosciences Limited (NSE:HESTERBIO) Q4 FY23 Earnings Concall dated May. 18, 2023. Corporate Participants: Bimal Lalitsingh Goculdas -- Chief Executive Officer Analysts: Abhishek Mehra -- TIL
Hester Biosciences Limited (NSE:HESTERBIO) Q4 FY23 Earnings Concall dated May. 17, 2023. Corporate Participants: Unidentified Speaker -- Analysts: Nirav Seksaria -- Living Root Capital --
AMI Organics Ltd (NSE:AMIORG) Q4 FY23 Earnings Concall dated May. 15, 2023. Corporate Participants: Bhavin Shah -- Chief Financial Officer Nareshkumar Ramjibhai Patel -- Executive Chairman
Dr Lal PathLabs Ltd (NSE:LALPATHLAB) Q4 FY23 Earnings Concall dated May. 11, 2023. Corporate Participants: Hon. Brig. Dr. Arvind Lal -- Executive Chairman Om
Dr. Reddy's Laboratories (NSE:DRREDDY) Q4 FY23 Earnings Concall dated May. 10, 2023. Corporate Participants: Richa Periwal -- Investor Relations G V Prasad -- Co-Chairman and Managing
Vijaya Diagnostics Centre limited is a leading diagnostic medicare services provider in Southern India and offers comprehensive services that include nuclear medicine,
Torrent Pharmaceuticals Ltd reported Total revenue for Q4 FY23 of ₹2,452 Crore, up from ₹ Crore year on year depicting a growth
Torrent Pharmaceuticals Ltd (NSE: TORNTPHARM) Q4 FY23 Earnings Concall dated May. 30, 2023 Corporate Participants: Sudhir Menon — Executive Director, (Finance) and Chief Financial
Supriya Lifescience Ltd (NSE:SUPRIYA) Q4 FY23 Earnings Concall dated May. 29, 2023. Corporate Participants: Irfan Raeen -- Investor Relations Satish Wagh --
Aurobindo Pharma Limited (NSE:AUROPHARMA) Q4 FY23 Earnings Concall dated May. 28, 2023. Corporate Participants: Deepti Thakur -- Investor Relations & Corporate Communications
SUN PHARMACEUTICAL INDUSTRIES LIMITED (NSE : SUNPHARMA) Q4 FY23 Earnings Concall dated May. 26, 2023. Corporate Participants: Abhishek Sharma -- Head of
GMM Pfaudler Limited (NSE: GMMPFAUDLR) Q4 FY23 Earnings Concall dated May. 26, 2023 Corporate Participants: Priyanka Daga — Deputy General Manager Tarak Patel — Managing Director
Max India Limited (NSE : MAXIND) Q4 FY23 Earnings Concall dated May. 26, 2023 Corporate Participants: Rajit Mehta -- Managing Director Ajay Agrawal -- Chief Financial
Sun Pharmaceuticals Ltd reported Total revenue for Q4 FY23 of ₹10,931 Crore, up from ₹9,447 Crore year on year depicting a growth
JB Chemicals & Pharmaceuticals Limited (NSE: JBCHEPHARM) Q4 FY23 Earnings Concall dated May. 25, 2023. Corporate Participants: Jason D'Souza -- Vice President,
Suven Pharma is in the business of Contract development & manufacturing organisation (CDMO), catering to the needs of global Pharma Industry. SPL
Key highlights from Sequent Scientific Limited (SEQUENT) Q4 FY23 Earnings Concall Q&A Highlights: [00:14:02] Vishwas asked about the utilization of the API
Key highlights from Glenmark Pharmaceuticals Limited (GLENMARK) Q4 FY23 Earnings Concall Q&A Highlights: [00:27:19] Tushar Manudhane at Motilal Oswal asked about the
Alkem Laboratories Ltd (NSE:ALKEM) Q4 FY23 Earnings Concall dated May. 19, 2023. Corporate Participants: Amit Khandelia -- Associate Vice President, Finance Sandeep Singh -- Managing Director
Key highlights from Divi's Laboratories Ltd (DIVISLAB) Q4 FY23 Earnings Concall Q&A Highlights: [00:11:30] Tushar Manudhane from Motilal Oswal asked if backward
Sun Pharma Advanced Research Company Ltd is engaged in the business of research and development (R&D) of pharmaceutical products. The company is